Innoviva (INVA) EBITDA Margin Growth (5y) (2016 - 2026)
Innoviva (INVA) EBITDA Margin Growth (5y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
| 10 |
Innoviva |
1.69 Bn |
1.08 Bn |
75.83 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
54,878.00 |
| Dec 31, 2025 |
635.00 |
| Sep 30, 2025 |
-6,312.00 |
| Jun 30, 2025 |
-4,739.00 |
| Mar 31, 2025 |
-5,000.00 |
| Dec 31, 2024 |
-95,029.00 |
| Sep 30, 2024 |
-4,415.00 |
| Jun 30, 2024 |
-3,848.00 |
| Mar 31, 2024 |
-115,334.00 |
| Dec 31, 2023 |
-52,719.00 |
| Sep 30, 2023 |
3,431.00 |
| Jun 30, 2023 |
-107,598.00 |
| Mar 31, 2023 |
-150,307.00 |
| Dec 31, 2022 |
-107,821.00 |
| Sep 30, 2022 |
-8,189.00 |
| Jun 30, 2022 |
-57,132.00 |
| Mar 31, 2022 |
-78,242.00 |
| Dec 31, 2021 |
-69,788.00 |
| Sep 30, 2021 |
1,280.00 |
| Jun 30, 2021 |
818,572.00 |
